SCHEMBL29328204

SCHEMBL29328204

Cc1ccc(-n2c(=O)c3c(C(F)(F)F)c4c(=O)n(-c5ccc(C(F)(F)F)cc5)c(=O)c4c(C(F)(F)F)c3c2=O)cc1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GSK3A P49840 1/20 0.45
GSK3B P49841 1/20 0.45
NPBWR1 P48145 1/20 0.45
MCHR1 Q99705 1/20 0.45
GAA P10253 1/20 0.40
ALDH1A1 P00352 3/20 0.39
PTGS2 P35354 2/20 0.39
GRM5 P41594 1/20 0.38
TRPV1 Q8NER1 1/20 0.38
NPC1 O15118 1/20 0.37
LMNA P02545 1/20 0.37
HSP90AA1 P07900 1/20 0.37
MAPT P10636 1/20 0.37
HPGD P15428 1/20 0.37
XBP1 P17861 1/20 0.37
MAPK1 P28482 1/20 0.37
HTT P42858 1/20 0.37
RAB9A P51151 1/20 0.37
SMN1; SMN2 Q16637 1/20 0.37
NPSR1 Q6W5P4 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5535450 0.92 GSK3A (0.47) GSK3AGSK3BNPBWR1MCHR1PTGS2
SCHEMBL17995365 0.87 GSK3A (0.45) GSK3AGSK3BNPBWR1MCHR1PTGS2
SCHEMBL22197877 0.83 GSK3A (0.47) GSK3AGSK3BNPBWR1MCHR1PTGS2
SCHEMBL5575888 0.83 NPBWR1 (0.43) GSK3AGSK3BNPBWR1MCHR1GAA
SCHEMBL17931792 0.81 GSK3A (0.56) GSK3AGSK3BNPBWR1MCHR1GAA
SCHEMBL5533650 0.81 GSK3A (0.42) GSK3AGSK3BTRPV1MAPK1NPSR1
SCHEMBL25965011 0.79 GSK3A (0.44) GSK3AGSK3BNPBWR1MCHR1PTGS2
SCHEMBL25599472 0.78 GSK3A (0.43) GSK3AGSK3BNPBWR1MCHR1PTGS2
SCHEMBL15356132 0.76 GSR (0.38) NPBWR1MCHR1HSP90AA1MAPTHPGD
SCHEMBL18925442 0.75 GSK3A (0.50) GSK3AGSK3BNPBWR1MCHR1GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240239825-A1 1,8-SUBSTITUTED CARBAZOLE-BASED PLATINUM COMPLEXES WITH HIGH RADIATION RATE AND APPLICATION THEREOF ZHEJIANG HUAXIAN PHOTOELECTRICITY TECHNOLOGY CO., LTD (CN) 2024-07-18 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240239825-A1 1,8-SUBSTITUTED CARBAZOLE-BASED PLATINUM COMPLEXES WITH HIGH RADIATION RATE AND APPLICATION THEREOF LIG3, VIM, TRIM33 GSK3A 708/4885GSK3B 668/4885NPBWR1 4829/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.